Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 44, 2022 - Issue 3
Submit an article Journal homepage
252
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway

Huixiang Yaoa Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
,
Jun Yanb Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
,
Li Yina Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
&
Wei Chena Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaCorrespondence[email protected]
Pages 437-446 | Received 18 Aug 2021, Accepted 11 Mar 2022, Published online: 23 Mar 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Peigen Wu, Churui Chang, Guanglin Zhu, Lixiang Zhai, Xu Zhang, Qiuchan Huan, Zhengxian Gao, Huan Deng, Yue Liang & Haitao Xiao. (2023) Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis. Drug Design, Development and Therapy 17, pages 1531-1546.
Read now

Articles from other publishers (3)

Fares E.M Ali, Islam M. Ibrahim, Osama M Ghogar, Esraa K. Abd-alhameed, Hanan S. Althagafy & Emad H.M. Hassanein. (2023) Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study. World Journal of Gastroenterology 29:6, pages 1026-1053.
Crossref
Jing Yang, Chao Zhong & Jun Yu. (2023) Natural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis. International Journal of Molecular Sciences 24:3, pages 2429.
Crossref
Consolato M. Sergi. (2022) NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection. Vaccines 10:8, pages 1307.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.